These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35291648)

  • 1. Recent Advances in Cell Therapeutics for Systemic Autoimmune Diseases.
    Park Y; Kwok SK
    Immune Netw; 2022 Feb; 22(1):e10. PubMed ID: 35291648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting Under the Skin: Targeting Cutaneous Autoimmune Disease.
    Vesely MD
    Yale J Biol Med; 2020 Mar; 93(1):197-206. PubMed ID: 32226348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three distinct tolerogenic CD14
    van Wigcheren GF; Roelofs D; Figdor CG; Flórez-Grau G
    J Autoimmun; 2021 Jun; 120():102645. PubMed ID: 33901801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerising cellular therapies: what is their promise for autoimmune disease?
    Mosanya CH; Isaacs JD
    Ann Rheum Dis; 2019 Mar; 78(3):297-310. PubMed ID: 30389690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treg Enhancing Therapies to Treat Autoimmune Diseases.
    Eggenhuizen PJ; Ng BH; Ooi JD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerizing Strategies for the Treatment of Autoimmune Diseases: From
    Cauwels A; Tavernier J
    Front Immunol; 2020; 11():674. PubMed ID: 32477325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation.
    Amodio G; Cichy J; Conde P; Matteoli G; Moreau A; Ochando J; Oral BH; Pekarova M; Ryan EJ; Roth J; Sohrabi Y; Cuturi MC; Gregori S
    Cancer Immunol Immunother; 2019 Apr; 68(4):661-672. PubMed ID: 30357490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far.
    Gilkeson GS
    Arthritis Rheumatol; 2022 May; 74(5):752-765. PubMed ID: 35128813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning immune suppression in systemic autoimmunity with self-derived peptides.
    Singh RP; Hahn BH; La Cava A
    Inflamm Allergy Drug Targets; 2008 Dec; 7(4):253-9. PubMed ID: 19075790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.
    Horwitz DA; Fahmy TM; Piccirillo CA; La Cava A
    Trends Immunol; 2019 Oct; 40(10):888-908. PubMed ID: 31601519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.
    Park MJ; Baek JA; Kim SY; Jung KA; Choi JW; Park SH; Kwok SK; Cho ML
    J Transl Med; 2020 Dec; 18(1):483. PubMed ID: 33317573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
    Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
    Front Immunol; 2019; 10():43. PubMed ID: 30804926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered antigen-specific regulatory T cells for autoimmune skin conditions.
    Mukhatayev Z; Ostapchuk YO; Fang D; Le Poole IC
    Autoimmun Rev; 2021 Mar; 20(3):102761. PubMed ID: 33476816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterial-based approaches to engineering immune tolerance.
    Emerson AE; Slaby EM; Hiremath SC; Weaver JD
    Biomater Sci; 2020 Dec; 8(24):7014-7032. PubMed ID: 33179649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders.
    Barnie PA; Zhang P; Lv H; Wang D; Su X; Su Z; Xu H
    Exp Ther Med; 2017 Feb; 13(2):378-388. PubMed ID: 28352304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells in Systemic Sclerosis.
    Frantz C; Auffray C; Avouac J; Allanore Y
    Front Immunol; 2018; 9():2356. PubMed ID: 30374354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
    Passeri L; Marta F; Bassi V; Gregori S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
    Sharabi A; Mozes E
    Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.